Production (Stage)
ALX Oncology Holdings Inc.
ALXO
$0.4637
-$0.0152-3.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.57% | 35.87% | 39.78% | -15.34% | -17.88% |
| Total Depreciation and Amortization | -1.40% | 3.38% | -1,380.00% | 54.52% | 0.47% |
| Total Amortization of Deferred Charges | 4.69% | 7.81% | 4.76% | 6.45% | 4.92% |
| Total Other Non-Cash Items | -12.95% | 7.74% | 20.41% | 26.17% | 7.13% |
| Change in Net Operating Assets | 107.54% | -2,746.53% | -109.36% | 328.81% | -148.20% |
| Cash from Operations | 34.97% | 19.23% | 18.56% | 16.22% | -36.34% |
| Capital Expenditure | 59.46% | 59.46% | -111.44% | 94.82% | 78.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.07% | 301.25% | 124.48% | -87.46% | -38.07% |
| Cash from Investing | 4.43% | 299.11% | 100.49% | -85.40% | -37.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -75.43% | -20.63% | -222.52% | -103.74% | -63.55% |
| Issuance of Common Stock | -- | -99.93% | -- | 6,854.22% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -87.70% | 108.16% | -- | -- | -- |
| Cash from Financing | -97.89% | -99.45% | 326.13% | 7,816.03% | 2,984.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.43% | -48.09% | 103.08% | 105.94% | -158.20% |